Personal InjuryWrongful Death Medical Malpractice Baby/Child Injury Defective Drugs
Car & Truck Accidents
Boat Accidents
Motorcycle Accidents Slip & Falls Dog Bites
Patient Neglect
Brain Injury
Negligence
Birth Injury
Lead Poisoning
Avandia ADHD Drugs/Adderall
Fosamax
Bextra
Celebrex ED Drugs / Viagra
ReNu with MoistureLoc
Complete MoisturePlus
Ortho Evra Patch
Paxil Zelnorm
Defective Medical Devices
|
Pharmaceutical Injuries - Zelnorm
Have You Sustained a Personal Injury from Zelnorm?
Novartis Pharmaceuticals’ irritable bowel syndrome drug—Zelnorm (tegaserod maleate)—was pulled from the United States market in March 2007 when the FDA received the results of a large-scale analysis linking the drug to an increased risk of serious cardiovascular problems including heart attack and stroke. The FDA has since urged patients still taking Zelnorm to seek medical attention immediately if they experience chest pains, shortness of breath, dizziness, or other heart attack or stroke symptoms.
Zelnorm is a prescription medication approved for short term treatment of women with irritable bowel syndrome (IBS) with constipation, and for all patients younger than 65 years with chronic constipation. On March 30, 2007, the U.S. Food and Drug Administration (FDA) requested that Novartis Pharmaceuticals stop marketing Zelnorm, after a new safety analysis found a higher chance of heart attack, stroke, and chest pain in patients treated with Zelnorm.
Information for Current Zelnorm Users
FDA is currently advising patients who are using Zelnorm to contact their health care providers to discuss treatment alternatives. Patients who are taking Zelnorm should seek emergency medical care if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking, or other symptoms of a heart attack or stroke. There may be patients for whom no other treatment options are available and in whom the benefits of Zelnorm treatment outweigh the chance of serious side effects. FDA will work with Novartis to allow access to Zelnorm for those patients through a special program.
Study Finds Health Risks
In late February and early March 2007, Novartis Pharmaceuticals gave FDA the results of new analyses of 29 clinical studies of Zelnorm for treatment of a variety of gastrointestinal tract conditions. These 29 studies included 11,614 patients treated with Zelnorm and 7,031 treated with a sugar pill. The average age of patients in these studies was 43 years and most patients (88%) were women.
The number of patients who suffered a heart attack, stroke or severe heart chest pain that can turn into a heart attack was small. However, patients treated with Zelnorm had a higher chance of having any of these serious and life-threatening side effects than did those who were treated with a sugar pill. Thirteen patients treated with Zelnorm (0.1%) had serious and life-threatening cardiovascular side effects; among these, four patients had a heart attack (one died), six had a type of severe heart chest pain which can quickly turn into a heart attack, and three had a stroke. Among the patients taking the sugar pill, only one (or 0.01%) had symptoms suggesting the beginning of a stroke that went away without complication.
Zelnorm - Getting Legal Help
While all medications have certain anticipated side effects, a drug manufacturer has a duty to make its products as reasonably safe as possible, and to inform the medical community and the public of known risks associated with its drugs. If a manufacturer fails to do so, it can be held legally responsible if patients are injured as the result of inadequate warnings or the unreasonably dangerous nature of the drug, under a legal theory called "product liability."
If you or a loved one have experienced any dangerous symptoms or unusual medical conditions while using Zelnorm, you should first contact your doctor or other healthcare professional. You may also wish to meet with an experienced attorney to discuss your options and to protect your right to a legal remedy for any injuries caused by Zelnorm use. NationWide Law Group would be honored to assist you.
Zelnorm’s maker has agreed to stop sales of the drug, but this does little to help those who have already suffered injury as a result of taking it. If you or a loved one has suffered a cardiovascular event or other serious side effect while taking Zelnorm, you may be able to hold Novartis responsible for your losses.
You can get a FREE consultation with a leading Personal Injury Attorney in your area who can offer sound legal help and assistance with your claim.
| Get a FREE Consultation with a Personal Injury Lawyer! |
|
Please Select Your State:
|
© 2007
|